8-K ·Filed Apr 28, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
This is a routine board retirement and size reduction with no material impact on the company's operations or financials. No immediate trading action warranted. Monitor the 2026 annual meeting for any further governance changes.
Final — all horizons settled through T+60d
FENC ▲ +59.58% at T+60d
NEUTRAL call +59.58% · α vs SPY +55.47% · entry $6.26 → $9.99
T+1d
+3.67%
call +3.67% · α +2.65%
$6.49
settled 6mo ago
T+5d
+14.70%
call +14.70% · α +11.59%
$7.18
settled 6mo ago
T+20d
+57.99%
call +57.99% · α +51.94%
$9.89
settled 5mo ago
T+60d
+59.58%
call +59.58% · α +55.47%
$9.99
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Director Rostislav Raykov will retire from the Board of Fennec Pharmaceuticals and not stand for re-election at the 2026 annual meeting. The Board will reduce its size from six to five directors, with no vacancies expected. This is a routine governance event with no financial impact.
Key Facts
- Director Rostislav Raykov notified the company of his retirement on April 27, 2026.
- He will not stand for re-election at the 2026 annual meeting.
- The Board resolved to reduce its size from six to five directors effective after the meeting.
- Departure is not due to any disagreement with the company's operations, policies, or practices.
- No replacement is needed as the board size is being reduced.
Financial Impact
None
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-050433 |
| Document: 0001104659-26-050433-index-headers.html | 0001104659-26-050433 |
| Document: 0001104659-26-050433-index.html | 0001104659-26-050433 |
| Document: 0001104659-26-050433.txt | 0001104659-26-050433 |
18 reports for FENC
100% Hit rate @ T+60 Went positive at some point 4 of 5 best @ T+60▲ +50.50%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | SC 13G/A | $10.27 | awaiting T+60 | — | $10.62 (+3.41%) |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | $10.62 (−11.72%) |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | $10.62 (−11.72%) |
Aug 11, 2026 11w ago | Press Release | $12.78 | awaiting T+60 | — | $10.62 (−16.90%) |
Jun 15, 2026 19w ago | Press Release | $9.19 $11.65 | ▲ +26.77% | ▲ +25.77% | $10.62 (+15.56%) |
May 22, 2026 22w ago | 8-K | $9.89 $11.87 | ▲ +20.02% | ▲ +17.30% | $10.62 (+7.38%) |
May 18, 2026 23w ago | 8-K | $9.76 $12.06 | ▲ +23.57% | ▲ +17.28% | $10.62 (+8.81%) |
May 14, 2026 23w ago | Press Release | $9.24 $10.94 | ▲ +18.40% | ▲ +14.81% | $10.62 (+14.94%) |
May 7, 2026 24w ago | Press Release | $6.90 $9.59 | ▲ +38.99% | ▲ +35.15% | $10.62 (+53.91%) |
Apr 28, 2026 26w ago | 8-K | $6.26 $9.99 | ▲ +59.58% | ▲ +55.47% | $10.62 (+69.65%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Thu (11h 50m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers